We won’t overcharge you through a subscription model. Our one off economical prices remain fixed all the time

Clinician-led weight management for  Cardiovascular Disease.

If you’ve had a heart attack, stroke, or have been told you have heart disease — weight management is one of the most important steps you can take. Our GLP-1 specialist clinicians work with your cardiac history.

Takes 5 minutes
· No commitment · Reviewed within 1 working day

photo 1571019613454 1cb2f99b2d8b
Programme members
7.6M
UK adults with heart/circulatory disease
Ellipse 276 3
Ellipse 275 (3)
Ellipse 274 (4)
Cardiovascular Disease.
Ellipse 276 3
7.6M

People living with heart and circulatory disease in the UK

Excess weight is one of the major modifiable cardiovascular risk factors. GLP-1 medicated weight management reduces blood pressure, improves lipid profiles, and lowers recurrent event risk.

Source: British Heart Foundation, 2024 · View source ↗

The Challenge

After a cardiac event, weight management is critical — but most people don't know where to start

Cardiac rehab is short-term — ongoing specialist support is left to you

NHS Cardiac Rehabilitation programmes are typically 6–8 weeks. After discharge, most patients are left with a leaflet and good intentions. Without ongoing specialist support, weight creeps back and cardiovascular risk rises again.
📖 British Heart Foundation — Cardiac Rehabilitation Audit, 2023

Post-cardiac anxiety makes specialist support even more important

Many people are anxious about exertion after a cardiac event. This is completely understandable — and it means specialist clinician guidance becomes even more critical to managing weight safely and effectively.

📖 NICE Guideline MI: Secondary Prevention — CG172, 2023

Long waits can delay progress

When weight is affecting your health, waiting months for support can feel frustrating. WeightFall gives you faster access to clinician-led weight management, starting with a review within 1 working day
📖 ESC Guidelines on Cardiovascular Disease Prevention, 2021
7.6M
Ellipse 655

UK adults living with heart or circulatory disease

📖 British Heart Foundation, UK CVD Statistics, 2024
80%
Ellipse 655

of cardiovascular disease is potentially preventable through lifestyle and weight management

📖 World Heart Federation, 2024
Ellipse 655 (1)
Ellipse 656 (1)

No need for subscriptions,

get weight management programme through us for the lowest price
The Programme Approach

A clinician-managed
programme built around your condition

WeightFall combines GLP-1 medication with specialist clinical oversight in a fully managed programme. It’s not a prescription-only service.
Clinician-prescribed · Condition-aware

Medicated Weight Management

GLP-1 medication assessed and prescribed by your GLP-1 specialist clinician, with dose titration specifically calibrated to your diabetes medication history, blood sugar control, and health profile.
01
Regular · Adaptive · Ongoing

3-Weekly Clinician Check-ins

Your dedicated GLP-1 specialist reviews your progress every 3 weeks — adjusting your dose, managing side effects, and evolving your plan as you respond. Not a one-off consultation.
02
Food · Movement · Mindset

Lifestyle & Habit Guidance

Food, movement, sleep and mindset coaching alongside your medication — with specific guidance on managing blood sugar through lifestyle, not just medication.
03
GLP-1 specialist clinicians · Reviewed within 1 working day
Member Stories

Real people, Verified outcomes

Condition-specific health metrics — not just numbers on a scale.
Takes 5 minutes · No commitment · Reviewed within 1 working day
The WeightFall Programme

Everything included — from £85/month

Every WeightFall programme includes the same level of clinical oversight, support and monitoring — regardless of which treatment your clinician recommends.

Clinical assessment & review

Your case reviewed by a GLP-1 specialist clinician before treatment begins. Condition-specific. Thorough. Personal.

Check-in every 3 weeks

Regular clinician review of your progress, dose and side effects. You’re never left to figure it out between appointments.

Dose adjustment support

Your plan adapts as you respond to treatment — no fixed templates. Dose escalation managed by your specialist throughout.

Lifestyle & habit guidance

Food, movement, sleep and mindset coaching alongside your treatment. Sustainable change, not just medication.

Fully online — no GP referral

Everything managed from home. A UK-registered clinician reviews your case and responds within 1 working day. Completely private.

Secure & confidential

Your health data handled with full clinical confidentiality. GDPR compliant. Secure encrypted platform.
Individual results vary. Data based on published clinical trial evidence. Your clinician will set realistic expectations for your specific case at assessment.

Your weight management journey

Week 1–4
Programme begins
Clinician reviews your case, dosing starts. First check-in at week 3. Most patients notice reduced appetite early on.
Month 1–3
Early progress
Appetite changes become more consistent. Dose adjusted as needed.
Month 3–6
Meaningful change
Progressive dose increases. Body weight reduction. Lifestyle coaching integrated alongside medication.
Month 6–12
Sustained results
Clinical trial shows body weight reduction. Clinician guides maintenance or tapering.
Programmes from
£85/month
Price varies by treatment type and dose. Your clinician confirms before any commitment.
If you’re not clinically eligible, you won’t be charged for treatment.

Evidence-based. Peer-reviewed. Regulated.

Every element of the WeightFall programme is grounded in clinical evidence. Our approach is informed by the highest-quality published studies — and updated as new evidence emerges.
01
PREDIMED Trial — NEJM 2013
Mediterranean diet reduced major cardiovascular events by 30% vs low-fat diet in high-risk participants — confirming diet quality is central to cardiac risk management.
02
ESC Guidelines — CVD Prevention, 2021
ESC recommends structured weight management as a core secondary prevention strategy for all patients with established cardiovascular disease.
03
NICE Guideline CG172 — Secondary Prevention post-MI, 2023
NICE recommends weight management as part of structured secondary prevention for all patients following myocardial infarction.

Regulatory statement (CAP Code 12.1): WeightFall is a clinician-led weight management service. All treatments are prescription-only and subject to clinical assessment by UK- registered clinicians. WeightFall does not diagnose, treat, or cure any medical condition. Clinicians are registered with the General Medical Council (GMC). This service is not a substitute for NHS care.

Your questions, answered

Condition-specific answers — straight from our clinical team.

Find Out If You're Eligible

We’ll ask you a few quick questions to help determine your eligibility for treatment. Your responses will remain private and confidential.
Frame 1321315189 1
Is this safe if I've had a heart attack or stroke?
You must inform your GP or cardiologist before making significant changes and follow their guidance. WeightFall is a managed weight management programme — it does not replace cardiac care. Your clinician will review your full cardiac history at assessment.
No. WeightFall provides clinician-led medicated weight management. It does not treat cardiovascular disease.
No — individual results vary significantly. No specific cardiovascular or health outcome is guaranteed.
Yes. WeightFall can complement NHS Cardiac Rehabilitation. Inform your cardiac rehab team that you are joining a private managed weight management programme.
Every 3 weeks your GLP-1 specialist clinician reviews your progress, weight, side effects, and plan — with your cardiac history in view throughout. Fully online.
Only your GP is notified. We don’t have direct access to cardiologists, so they are not informed.
If a clinician determines treatment isn’t clinically appropriate, your payment for that order is refunded.
First treatment dose, clinical assessment review, clinician sign-off, and first 3-weekly check-in. Prices vary by treatment type and dose — full breakdown before commitment.
No. Treatment is reviewed continuously. Your clinician guides you on tapering if you choose to stop.
Yes. Your clinician reviews your full medication list as part of the assessment. GLP-1 medication interactions with cardiac drugs are assessed before any prescription is made.
Your medical history is assessed by a specialist clinician before initiation of treatment to ensure clinical safety.
Yes. Our UK-registered clinicians assess your suitability independently. However, we strongly recommend informing your GP or cardiologist before starting.